Anne-Christine Hick1, Michel Malaise2, Damien Loeuille3,4, Thierry Conrozier5, Yves Maugars6, Franz Pelousse7, Cédric Tits8, Yves Henrotin1,9,10. 1. ARTIALIS SA, CHU Sart-Tilman, Liège, Belgium. 2. Department of Rheumatology, CHU Sart Tilman, University of Liège, Liège, Belgium. 3. Department of Rheumatology, University Hospital of Nancy, Vandœuvre-lès-Nancy, France. 4. UMR 7365 CNRS-Université de Lorraine IMoPA, Biopôle de l'Université de Lorraine, Campus Brabois-Santé, Vandoeuvre-Lès-Nancy, France. 5. Department of Rheumatology, Hôpital Nord Franche-Comté, Belfort, France. 6. Service de rhumatologie, Hôtel-Dieu, CHU de Nantes, France. 7. SODIRAY, Solution Diagnostique Radiologique, Liège, Belgium. 8. DNAlytics, Louvain-la-Neuve, Belgium. 9. Bone and Cartilage Research Unit, Arthropole Liège, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, CHU Sart-Tilman, Liège, Belgium. 10. Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Vivalia, Marche-en-Famenne, Belgium.
Abstract
OBJECTIVE: To assess the cross-sectional association between serum levels of Coll2-1 and Coll2-1NO2, two cartilage degradation biomarkers; the burden of magnetic resonance imaging (MRI) features and clinical outcomes; and to evaluate the predictive value of these biomarkers on progression. DESIGN: A total of 121 subjects with knee osteoarthritis (OA) were followed during 1 year with pain, function, and MRI assessment (PRODIGE study). Type II collagen-specific biomarker Coll2-1 and its nitrated form Coll2-1NO2 were directly measured in serum using immunoassays at baseline and after 3-, 6-, and 12-month follow-up. RESULTS: Serum Coll2-1 and Coll2-1NO2 were correlated with several baseline knee features quantified with Whole-Organ Magnetic Resonance Imaging Score (WORMS). Coll2-1 was significantly correlated with periarticular cysts/bursitis (ρ = 0.29, P < 0.01), subarticular bone attrition (ρ = 0.25, P = 0.01), subarticular cysts (ρ = 0.24, P = 0.02), and articular cartilage integrity (ρ = 0.23, P = 0.03) WORMS subscores for the whole joint as well as with the medial femorotibial joint sum score (ρ = 0.26, P = 0.01) and medial femorotibial joint cartilage (ρ = 0.23, P = 0.02). Coll2-1NO2 correlated with WORMS total score (ρ = 0.23, P = 0.02), WORMS scores in the patellofemoral (ρ = 0.23, P = 0.02) and medial femorotibial compartments (ρ = 0.21, P = 0.03), with osteophytes scores (ρ = 0.27, P < 0.01), subarticular cysts (ρ = 0.24, P = 0.019), and intraarticular loose bodies (ρ = 0.27, P = 0.007). Baseline Coll2-1NO2 was higher in subjects with a pain worsening (426.4 pg/mL [278.04-566.95]) as compared to non-progressors (306.84 pg/mL [200.37-427.84]) over 1 year (AUC = 0.655, P = 0.015). CONCLUSION: Serum cartilage biomarkers Coll2-1 and Coll2-1NO2 are associated with several knee OA features quantified with WORMS. Our study also shows that the baseline value of Coll2-1NO2 is positively associated with pain worsening.
OBJECTIVE: To assess the cross-sectional association between serum levels of Coll2-1 and Coll2-1NO2, two cartilage degradation biomarkers; the burden of magnetic resonance imaging (MRI) features and clinical outcomes; and to evaluate the predictive value of these biomarkers on progression. DESIGN: A total of 121 subjects with knee osteoarthritis (OA) were followed during 1 year with pain, function, and MRI assessment (PRODIGE study). Type II collagen-specific biomarker Coll2-1 and its nitrated form Coll2-1NO2 were directly measured in serum using immunoassays at baseline and after 3-, 6-, and 12-month follow-up. RESULTS: Serum Coll2-1 and Coll2-1NO2 were correlated with several baseline knee features quantified with Whole-Organ Magnetic Resonance Imaging Score (WORMS). Coll2-1 was significantly correlated with periarticular cysts/bursitis (ρ = 0.29, P < 0.01), subarticular bone attrition (ρ = 0.25, P = 0.01), subarticular cysts (ρ = 0.24, P = 0.02), and articular cartilage integrity (ρ = 0.23, P = 0.03) WORMS subscores for the whole joint as well as with the medial femorotibial joint sum score (ρ = 0.26, P = 0.01) and medial femorotibial joint cartilage (ρ = 0.23, P = 0.02). Coll2-1NO2 correlated with WORMS total score (ρ = 0.23, P = 0.02), WORMS scores in the patellofemoral (ρ = 0.23, P = 0.02) and medial femorotibial compartments (ρ = 0.21, P = 0.03), with osteophytes scores (ρ = 0.27, P < 0.01), subarticular cysts (ρ = 0.24, P = 0.019), and intraarticular loose bodies (ρ = 0.27, P = 0.007). Baseline Coll2-1NO2 was higher in subjects with a pain worsening (426.4 pg/mL [278.04-566.95]) as compared to non-progressors (306.84 pg/mL [200.37-427.84]) over 1 year (AUC = 0.655, P = 0.015). CONCLUSION: Serum cartilage biomarkers Coll2-1 and Coll2-1NO2 are associated with several knee OA features quantified with WORMS. Our study also shows that the baseline value of Coll2-1NO2 is positively associated with pain worsening.
Authors: Thao Pham; Désirée Van Der Heijde; Marissa Lassere; Roy D Altman; Jennifer J Anderson; Nicholas Bellamy; Marc Hochberg; Lee Simon; Vibeke Strand; Thasia Woodworth; Maxime Dougados Journal: J Rheumatol Date: 2003-07 Impact factor: 4.666
Authors: Gabby B Joseph; Stephanie W Hou; Lorenzo Nardo; Ursula Heilmeier; Michael C Nevitt; Charles E McCulloch; Thomas M Link Journal: Skeletal Radiol Date: 2016-02-27 Impact factor: 2.199
Authors: Willem Evert Van Spil; Olga Kubassova; Mikael Boesen; Anne-Christine Bay-Jensen; Ali Mobasheri Journal: Biochem Pharmacol Date: 2019-03-01 Impact factor: 5.858
Authors: G B Joseph; M C Nevitt; C E McCulloch; J Neumann; J A Lynch; U Heilmeier; N E Lane; T M Link Journal: Osteoarthritis Cartilage Date: 2018-05-23 Impact factor: 6.576
Authors: F W Roemer; M C Nevitt; D T Felson; J Niu; J A Lynch; M D Crema; C E Lewis; J Torner; A Guermazi Journal: Osteoarthritis Cartilage Date: 2012-07-27 Impact factor: 6.576
Authors: Bumsup Lee; Javad Parvizi; Dale Bramlet; David W Romness; Ali Guermazi; Moon Noh; Nipun Sodhi; Anton Khlopas; Michael A Mont Journal: J Knee Surg Date: 2019-01-04 Impact factor: 2.757
Authors: M Deberg; J-E Dubuc; A Labasse; C Sanchez; E Quettier; A Bosseloir; J-M Crielaard; Y Henrotin Journal: Ann Rheum Dis Date: 2007-07-20 Impact factor: 19.103
Authors: Anne C Bay-Jensen; Ali Mobasheri; Christian S Thudium; Virginia B Kraus; Morten A Karsdal Journal: Curr Opin Rheumatol Date: 2022-01-01 Impact factor: 5.006